Stroke: advances in therapy.
Schellinger
Peter D
PD
Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400-Kopfklinik, D-69120 Heidelberg, Germany.
Hacke
Werner
W
D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D016893:Carotid Stenosis / Q000150:complications / Q000601:surgery*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D001026:Coronary Artery Bypass; D004359:Drug Therapy, Combination; D016894:Endarterectomy, Carotid; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009203:Myocardial Infarction / Q000601:surgery; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality / Q000517:prevention & control / Q000601:surgery*; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; C069588:salivary plasminogen activator alpha 1, Desmodus rotundus; D000077144:Clopidogrel; D010960:Plasminogen Activators; D013988:Ticlopidine; D001241:Aspirin